Anbio Biotechnology (NASDAQ:NNNN – Get Free Report) gapped down prior to trading on Monday . The stock had previously closed at $9.49, but opened at $9.02. Anbio Biotechnology shares last traded at $9.9150, with a volume of 2,723 shares traded.
Analyst Ratings Changes
Separately, Weiss Ratings raised Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, May 14th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has an average rating of “Hold”.
Read Our Latest Research Report on NNNN
Anbio Biotechnology Stock Performance
Anbio Biotechnology Company Profile
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.
Featured Articles
- Five stocks we like better than Anbio Biotechnology
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
- Amazon’s AI Spending Is About to Face Its Most Important AWS Test Yet
- AI Data Centers Need Power, and These 2 Industrials Are Cashing In
Receive News & Ratings for Anbio Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anbio Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
